Viracta Therapeutics, Inc. VIRX
0.01 USD 0.00 (+0.00%)
At closeJul 2, 2026, 4:00 PM EDT
0.07 +0.06 +625.97%
After hours · Jul 2, 4:00 PM ET
0.00978 Day range 0.00978
0.13 52-week range 1.31
- YTD
- -93.92%
- 1 year
- -93.89%
Analyst view
Price target (mean) 3.00
Ratings (0m) 1 0 buy · 1 hold · 0 sell
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.195 | -0.26 – -0.13 | -0.35 | +44.3% | 0 | 0.0% | 2 |
| Current year | -0.90 | -1.00 – -0.80 | -1.32 | +31.8% | 0 | 0.0% | 2 |
| Next year | -0.385 | -0.41 – -0.36 | -0.90 | +57.2% | 3.50M | 0.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 14, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 16, 2024 | Leerink Partners | Downgrade | Outperform | Market Perform |
| Aug 15, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| May 23, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Apr 17, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Apr 16, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 12, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 5, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 10, 2023 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 5, 2023 | RBC Capital | Reiterated | Outperform | Outperform |
| Aug 15, 2023 | RBC Capital | Reiterated | Outperform | Outperform |
| Aug 15, 2023 | SVB Securities | Maintained | Outperform | Outperform |
| Aug 15, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 31, 2023 | EF Hutton | Initiated | — | Buy |
| Jul 5, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 10, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 9, 2023 | RBC Capital | Maintained | — | Outperform |
| May 8, 2023 | SVB Securities | Maintained | Outperform | Outperform |
| Mar 27, 2023 | Oppenheimer | Maintained | — | Outperform |
| Mar 14, 2023 | RBC Capital | Reiterated | — | Outperform |
| Mar 14, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Nov 11, 2022 | RBC Capital | Maintained | — | Outperform |
| Nov 10, 2022 | SVB Securities | Maintained | Outperform | Outperform |
| May 3, 2021 | HC Wainwright & Co. | Initiated | — | Buy |
| Apr 26, 2021 | SVB Leerink | Initiated | — | Outperform |
| Mar 25, 2021 | Evercore ISI Group | Initiated | — | Outperform |